Identification, evaluation, and management of children with autism spectrum disorder
SL Hyman, SE Levy, SM Myers, DZ Kuo, S Apkon… - …, 2020 - publications.aap.org
Autism spectrum disorder (ASD) is a common neurodevelopmental disorder with reported
prevalence in the United States of 1 in 59 children (approximately 1.7%). Core deficits are …
prevalence in the United States of 1 in 59 children (approximately 1.7%). Core deficits are …
[HTML][HTML] An update on psychopharmacological treatment of autism spectrum disorder
R Aishworiya, T Valica, R Hagerman, B Restrepo - Neurotherapeutics, 2023 - Elsevier
While behavioral interventions remain the mainstay of treatment of autism spectrum disorder
(ASD), several potential targeted treatments addressing the underlying neurophysiology of …
(ASD), several potential targeted treatments addressing the underlying neurophysiology of …
[HTML][HTML] Intranasal oxytocin in children and adolescents with autism spectrum disorder
L Sikich, A Kolevzon, BH King… - … England Journal of …, 2021 - Mass Medical Soc
Background Experimental studies and small clinical trials have suggested that treatment
with intranasal oxytocin may reduce social impairment in persons with autism spectrum …
with intranasal oxytocin may reduce social impairment in persons with autism spectrum …
Autism spectrum disorder: classification, diagnosis and therapy
Abstract Autism Spectrum Disorder (ASD) refers to a group of neurodevelopmental disorders
including autism, Asperger's syndrome (AS) and pervasive developmental disorder-not …
including autism, Asperger's syndrome (AS) and pervasive developmental disorder-not …
An overview of autism spectrum disorder, heterogeneity and treatment options
Since the documented observations of Kanner in 1943, there has been great debate about
the diagnoses, the sub-types, and the diagnostic threshold that relates to what is now known …
the diagnoses, the sub-types, and the diagnostic threshold that relates to what is now known …
Safety of 80 antidepressants, antipsychotics, anti‐attention‐deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric …
Mental disorders frequently begin in childhood or adolescence. Psychotropic medications
have various indications for the treatment of mental disorders in this age group and are used …
have various indications for the treatment of mental disorders in this age group and are used …
The health status of adults on the autism spectrum
Compared to the general pediatric population, children with autism have higher rates of co-
occurring medical and psychiatric illnesses, yet very little is known about the general health …
occurring medical and psychiatric illnesses, yet very little is known about the general health …
Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement
AD Kline, JF Moss, A Selicorni, AM Bisgaard… - Nature Reviews …, 2018 - nature.com
Abstract Cornelia de Lange syndrome (CdLS) is an archetypical genetic syndrome that is
characterized by intellectual disability, well-defined facial features, upper limb anomalies …
characterized by intellectual disability, well-defined facial features, upper limb anomalies …
Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology
An expert review of the aetiology, assessment, and treatment of autism spectrum disorder,
and recommendations for diagnosis, management and service provision was coordinated …
and recommendations for diagnosis, management and service provision was coordinated …
Cannabinoid treatment for autism: a proof-of-concept randomized trial
A Aran, M Harel, H Cassuto, L Polyansky, A Schnapp… - Molecular autism, 2021 - Springer
Background Endocannabinoid dysfunction in animal models of autism spectrum disorder
(ASD) and accumulating, albeit anecdotal, evidence for efficacy in humans motivated this …
(ASD) and accumulating, albeit anecdotal, evidence for efficacy in humans motivated this …